RCKT Sale Disclosure
Wilson Martin · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$256.46K
Wilson Martin General Counsel
RCKT
Transaction date
Sep 11, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 5 days later
RCKT daily price context
Close on/before transaction
$3.35
Sep 11, 2026
Close before public filing
$3.41
Sep 15, 2026
Return since public filing
+3.52%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 75,364 shares @ $3.4
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-036688
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$256.46K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rocket Pharmaceuticals, Inc. RCKT Current | Sale | Sep 11, 2026 | $256.46K |